Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharma...
Jul 24, 2025, 8:00 AM EDT - 9 days ago
Jul 18, 2025, 8:00 AM EDT - 15 days ago
Jun 18, 2025, 9:15 AM EDT - 6 weeks ago
Jun 11, 2025, 9:30 AM EDT - 7 weeks ago
Jun 5, 2025, 8:30 AM EDT - 2 months ago
Jun 2, 2025, 8:30 AM EDT - 2 months ago
May 29, 2025, 8:30 AM EDT - 2 months ago
May 21, 2025, 9:00 AM EDT - 2 months ago
May 15, 2025, 8:00 AM EDT - 2 months ago
May 7, 2025, 8:00 AM EDT - 3 months ago
Mar 19, 2025, 8:00 AM EDT - 4 months ago
Feb 26, 2025, 8:00 AM EST - 5 months ago
Feb 21, 2025, 8:00 AM EST - 5 months ago
Feb 18, 2025, 8:00 AM EST - 5 months ago
Jan 28, 2025, 8:00 AM EST - 6 months ago
Jan 7, 2025, 8:00 AM EST - 7 months ago
Dec 23, 2024, 7:30 AM EST - 7 months ago
Dec 12, 2024, 8:30 AM EST - 8 months ago
Dec 3, 2024, 1:40 PM EST - 8 months ago
Dec 3, 2024, 7:30 AM EST - 8 months ago
Nov 21, 2024, 7:00 AM EST - 9 months ago
Sep 26, 2024, 4:00 PM EDT - 11 months ago
Sep 4, 2024, 7:30 AM EDT - 11 months ago
Aug 20, 2024, 7:30 AM EDT - 1 year ago
Aug 12, 2024, 8:30 AM EDT - 1 year ago
Jul 2, 2024, 8:30 AM EDT - 1 year ago
Jun 17, 2024, 4:10 PM EDT - 1 year ago
May 30, 2024, 8:30 AM EDT - 1 year ago
Apr 16, 2024, 8:30 AM EDT - 1 year ago
Apr 2, 2024, 8:30 AM EDT - 1 year ago
Mar 29, 2024, 4:44 PM EDT - 1 year ago
Mar 26, 2024, 8:30 AM EDT - 1 year ago
Mar 22, 2024, 8:30 AM EDT - 1 year ago
Mar 14, 2024, 8:30 AM EDT - 1 year ago
Mar 7, 2024, 8:30 AM EST - 1 year ago
Mar 5, 2024, 8:30 AM EST - 1 year ago
Feb 13, 2024, 4:05 PM EST - 1 year ago
Dec 16, 2023, 12:25 PM EST - 1 year ago